[
    "{\"step_by_step_thinking\": \"Based on the provided documents, golimumab has failed to show any benefit in those with pulmonary sarcoidosis. Document [1] states that neither ustekinumab nor golimumab demonstrated efficacy in pulmonary sarcoidosis. Document [2] also mentions that golimumab has failed to show any benefit in those with pulmonary sarcoidosis. Therefore, the answer is B. no.\", \"answer_choice\": \"B. no\"}"
]